The Motley Fool

ALL ORDINARIES finishes higher Tuesday: 8 shares you missed

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Tuesday.

Here’s a short recap of the Australian market:

  • S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.30% to 6,079.10
  • ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) higher 0.33% to 6,148.70
  • AUD/USD at US 71 cents
  • Gold at US$1,308.42 an ounce
  • Brent Oil at US$61.88 a barrel

The best-performing ASX 200 share today was Ausdrill Limited (ASX: ASL), its share price rose by 7.2%.

Shares of Pact Group Holdings Ltd (ASX: PGH) were down nearly 10% after announcing some guidance about its upcoming result.

The REA Group Limited (ASX: REA) share price rose 4.5% with investors seemingly liking the value on offer at yesterday’s close price.

The share price of Challenger Ltd (ASX: CGF) ended the day up 1.2% after reporting its half-year result.

Transurban Group (ASX: TCL) shares went down 1.9% today due to releasing its half-year report to the market.

The Macquarie Group Ltd (ASX: MQG) share price ended the day up more than 2% after saying that profit growth could be up to 15% in FY19.

Shares of healthcare product distributor Paragon Care Ltd (ASX: PGC) declined 12% today due to revealing that a part of its business wasn’t performing well.

Finally, the share price of Blue Sky Alternative Investments Ltd (ASX: BLA) went up 41% after reporting its half year result.

Here are some of today’s top stories:

Macquarie has shown year after year why owning quality ASX shares pays dividends (literally), which is why these ASX blue chip shares could be worth considering for your portfolio too.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited and Paragon Care Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited and Transurban Group. The Motley Fool Australia has recommended Paragon Care Limited and REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more